Gapping down in reaction to disappointing earnings/guidance/SSS: WAG -3.5%, PDLI -3.0%... Select European financials showing weakness: RBS -6.9% (Times reported Britain's Treasury took control of the bank's bonus pool), LYG -4.6%, ING -4.0%, CS -2.8%, BCS -1.4% (FT reports that co receives surprise 1 bln pounds in BGI sale and DJ reports that co says impairment guidance unchanged by Dubai events)... Other news: HEB -28.3% (receives Complete Response Letter from FDA on Ampligen New Drug Application for chronic fatigue syndrome), RGNC -5.8% (files for common unit shelf offering and announces 10 mln common unit offering), SWS -5.4% (announces a 4.1 mln share common stock offering pursuant to an effective shelf), SEED -4.0% (still checking), CLFC -3.3% (raising gross proceeds of $12.8 million in private placement of common stock), CAST -2.7% (prices 5.93 mln common share offering at $6.85/share), SAP -1.9% (still checking for anything specific), NOK -0.7% (sets key financial targets and devices & services operational priorities for 2010)... Analyst comments: STZ -2.6% (downgraded to Sell from Neutral at Goldman- Reuters), MTL -2.1% (downgraded to Underperform from Neutral at Credit Suisse), MITI -2.1% (light volume; downgraded to Hold from Buy at Canaccord), ALK -1.3% (downgraded to Underweight at Morgan Stanley), POM -1.2% (downgraded to Neutral at Credit Suisse),
Gapping up in reaction to strong earnings/guidance: GIII +9.1% (light volume), GAME +3.2%, SNDA +3.1%... Select metals.mining names showing continued strength: HL +3.6%, GSS +3.6%, NG +3.0%, KGC +2.4%, AUY +2.3%, RTP +2.1%, EGO +2.0%, BBL +1.8%, MT +1.6%, GOLD +1.6%, AU +1.5%, GDX +1.5%, ABX +1.4%, GG +1.3%, BHP +1.2%, GLD +1.1%... Select airline names showing strength following Morgan Stanley upgrade of the sector: AMR +4.5%, AAI +4.3%, ALGT +3.5%, DAL +3.3%, UAUA +2.9%, JBLU +2.7%, LUV +1.6%, ALGT +1.5% (reports November '09 traffic; RPMs increased 19.5% y/y and ASMs increased 25.3%)... Other news: DYAX +27.4% (announces FDA approval of KALBITOR (ecallantide) for the treatment of acute attacks of hereditary angioedema in patients 16 years of age and older), ABCW +26.1% (announces investment agreement), SNTS +25.9% (announces FDA approval of Schering-Plough HealthCare Products' ZEGERID OTC), RAME +8.0% (reports 2009 production expected to meet or exceed prior guidance and says that all changes to financial statements are non-cash items, results in increase to net income for 2008 through first nine months of 2009), NVAX +7.5% (reports 'positive' clinical results from pivotal study of H1N1 influenza vaccine in Mexico), HEAT +3.0% (profiled in New America section of IBD), GSIT +2.9% (still checking)... Analyst comments: RFMD +3.6% (upgraded to Buy from Neutral at UBS), KBH +3.0% (upgraded to Outperform from Neutral at Credit Suisse), ARRS +2.9% (upgraded to Buy from Neutral at UBS), AGO +2.6% (upgraded to Outperform from Market Perform at Keefe Bruyette), SYY +2.4% (upgraded to Buy from Hold at BB&T), HDB +2.2% (upgraded to Buy at Deutsche), STI +1.8% (upgraded to Outperform from Neutral at Credit Suisse).